Display options
Cite
Barden J, Edwards JE, McQuay HJ, et al. Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC Anesthesiol. 2002;2(1):4doi: 10.1186/1471-2253-2-4.
Barden, J., Edwards, J. E., McQuay, H. J., & Moore, R. A. (2002). Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC anesthesiology, 2(1), 4. https://doi.org/10.1186/1471-2253-2-4
Barden, Jodie, et al. "Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review." BMC anesthesiology vol. 2,1 (2002): 4. doi: https://doi.org/10.1186/1471-2253-2-4
Barden J, Edwards JE, McQuay HJ, Moore RA. Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC Anesthesiol. 2002 Jun 09;2(1):4. doi: 10.1186/1471-2253-2-4. PMID: 12069696; PMCID: PMC116676.
Copy Download .nbib Format: NLM
Share it on

BMC Anesthesiol. 2002 Jun 09;2(1):4. doi: 10.1186/1471-2253-2-4.

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review.

BMC anesthesiology

Jodie Barden, Jayne E Edwards, Henry J McQuay, R Andrew Moore

Affiliations

  1. Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford Radcliffe Hospital, The Churchill, Headington Oxford OX3 7LJ, UK. [email protected]

PMID: 12069696 PMCID: PMC116676 DOI: 10.1186/1471-2253-2-4

Abstract

BACKGROUND: Rofecoxib is a cyclo-oxygenase 2 selective inhibitor. This systematic review of rofecoxib in acute pain examined studies in adults of analgesic efficacy over six hours, the amount and quality of the evidence on extended duration of analgesia, and the quality and quantity of evidence on adverse events. METHODS: Cochrane Library (issue 4, 2001), Biological Abstracts (March 2002), MEDLINE (March 2002) and PubMed (March 2002) were searched using rofecoxib as a free text term. The area under the pain relief versus time curve was dichotomized using validated equations to derive the proportion of patients on rofecoxib 50 mg or placebo with at least 50% pain relief over six hours. This was used to calculate the number needed to treat for at least 50% pain relief over six hours for rofecoxib compared with placebo. Information on duration of analgesia and adverse events was also collected. RESULTS: Five included trials investigated 1,118 patients, of whom 211 received placebo and 464 received rofecoxib 50 mg. The NNT for rofecoxib 50 mg was 2.3 (95% confidence interval 2.0 to 2.6). The weighted mean remedication time was 1.9 hours for placebo (126 patients), 7.4 hours for ibuprofen 400 mg (97 patients) and 13.6 hours for rofecoxib 50 mg (322 patients). CONCLUSION: Rofecoxib at 2-4 times the standard daily dose for chronic pain is an effective single dose oral analgesic in acute pain. Limitations in trial reporting constrain conclusions about longer duration of analgesia and adverse event profile.

References

  1. Lancet. 1998 Aug 22;352(9128):609-13 - PubMed
  2. J Clin Anesth. 2001 Mar;13(2):94-7 - PubMed
  3. Clin Ther. 2001 Sep;23(9):1446-55 - PubMed
  4. Br J Anaesth. 2002 Jan;88(1):72-7 - PubMed
  5. Pain. 2000 Dec 1;88(3):287-94 - PubMed
  6. Pain. 1997 Jan;69(1-2):127-30 - PubMed
  7. Clin Ther. 1999 Oct;21(10):1653-63 - PubMed
  8. Pain. 1996 Feb;64(2):331-5 - PubMed
  9. Pain. 1997 Feb;69(3):311-5 - PubMed
  10. J Clin Epidemiol. 2000 May;53(5):477-84 - PubMed
  11. BMJ. 1994 Dec 10;309(6968):1542-6 - PubMed
  12. Clin Pharmacol Ther. 1988 Apr;43(4):376-80 - PubMed
  13. Pharmacol Rev. 1957 Mar;9(1):59-209 - PubMed
  14. Br J Anaesth. 1982 Mar;54(3):279-84 - PubMed
  15. Pain. 1996 Aug;66(2-3):229-37 - PubMed
  16. J Pharmacol Exp Ther. 1953 Dec;109(4):393-400 - PubMed
  17. Pain. 1999 Jun;81(3):289-97 - PubMed
  18. Lancet. 1999 Nov 27;354(9193):1896-900 - PubMed
  19. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):831-6 - PubMed
  20. J Clin Epidemiol. 2000 Nov;53(11):1119-29 - PubMed
  21. Cochrane Database Syst Rev. 2000;(2):CD001548 - PubMed
  22. Cochrane Database Syst Rev. 2000;(2):CD001547 - PubMed
  23. J Health Serv Res Policy. 2002 Jan;7(1):51-61 - PubMed
  24. Clin Pharmacol Ther. 1999 Mar;65(3):336-47 - PubMed
  25. J Pain Symptom Manage. 1999 Dec;18(6):427-37 - PubMed
  26. Pain. 2000 Apr;85(3):415-24 - PubMed
  27. Ann Intern Med. 1987 Aug;107(2):224-33 - PubMed
  28. Control Clin Trials. 1996 Feb;17(1):1-12 - PubMed
  29. Anesthesiology. 2002 Mar;96(3):725-41 - PubMed
  30. Br J Clin Pharmacol. 1997 Jul;44(1):85-90 - PubMed
  31. Am J Epidemiol. 2000 Mar 1;151(5):488-96 - PubMed
  32. Arch Intern Med. 1996 Mar 25;156(6):661-6 - PubMed
  33. Ann Med. 1995 Apr;27(2):249-56 - PubMed
  34. J Pain Symptom Manage. 1999 Mar;17(3):164-74 - PubMed
  35. Clin Ther. 1999 Jun;21(6):943-53 - PubMed
  36. Am J Orthop (Belle Mead NJ). 2001 Jan;30(1):40-8 - PubMed
  37. Arch Intern Med. 2000 Mar 27;160(6):777-84 - PubMed
  38. Pain. 1998 Dec;78(3):209-16 - PubMed
  39. Br J Anaesth. 2002 Feb;88(2):227-33 - PubMed
  40. Br J Clin Pharmacol. 1981 Aug;12(2):117-22 - PubMed

Publication Types